# Modified Shenling Baizhu Powder for Allergic Asthma With Spleen Deficiency and Dampness Accumulation Syndrome

> **NCT07352488** · NA · NOT_YET_RECRUITING · sponsor: **Henan University of Traditional Chinese Medicine** · enrollment: 400 (estimated)

## Conditions studied

- Allergic Asthma

## Interventions

- **DRUG:** Modified Shenling Baizhu Powder
- **DRUG:** Placebo
- **DRUG:** Budesonide and Formoterol Fumarate Powder for Inhalation

## Key facts

- **NCT ID:** NCT07352488
- **Lead sponsor:** Henan University of Traditional Chinese Medicine
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2026-01-15
- **Primary completion:** 2027-09-30
- **Final completion:** 2028-03-31
- **Target enrollment:** 400 (ESTIMATED)
- **Last updated:** 2026-01-20


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07352488

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07352488, "Modified Shenling Baizhu Powder for Allergic Asthma With Spleen Deficiency and Dampness Accumulation Syndrome". Retrieved via AI Analytics 2026-07-13 from https://api.ai-analytics.org/clinical/NCT07352488. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*